Full Coverage

News about RSV

Top news

FDA Approves Clesrovimab-Cfor Vaccine to Protect Infants from Severe RSV Infections

16 hours ago

FDA Approves Merck’s Enflonsia for RSV Prevention, Competing with Beyfortus

11 hours ago

Medical Dialogues

FDA Approves Clesrovimab to Prevent RSV in Infants

2 days ago

By Kamal Kohli

Why RSV prevention for infants is still years away in India

6 days ago

By Daphne Clarance

Contemporary Pediatrics

RX Review: RSV prevention and pediatric hospitalization

5 days ago

All coverage

Contemporary Pediatrics

Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD

2 days ago

By Octavio Ramilo

RX Review: Clesrovimab, RSV Education, and Immunization Uptake

6 days ago

FDA Approves Merck’s Monoclonal Antibody for RSV Prevention in Infants

14 hours ago

RX Review: Evolving RSV Strategies Call for Multispecialty Collaboration

6 days ago

Contemporary Pediatrics

RX Review: Expanding options and addressing gaps in RSV prevention

5 days ago

By Joanne M. Nazif & Tina Q. Tan

RX Review: RSV Prevention Strategies and the Changing Epidemiologic Landscape

6 days ago

Contemporary Pediatrics

RX Review: Collaborating to strengthen RSV prevention efforts

5 days ago

By Joanne M. Nazif & Tina Q. Tan

FDA Approves Clesrovimab-cfor Vaccine to Prevent RSV in Infants During First Season

2 days ago

FDA Approves Merck’s Monoclonal Antibody Treatment for RSV in Infants

2 days ago

FDA Approves Clesrovimab-Cfor Vaccine to Protect Infants from Severe RSV During First Exposure Season

2 days ago

FDA Approves Merck’s Enflonsia as RSV Prevention Drug Competing with Beyfortus

2 days ago

Search

Clear search

Close search

Google apps

Main menu